ArticleFrontiers in neurology2026
Using the CHOPS score to evaluate the severe cerebral venous sinus thrombosis progression risk after anticoagulation.
Article in Frontiers in neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This aimed to evaluate the risk of severe cerebral venous sinus thrombosis (SCVST) progression after anticoagulation using clinical and radiological data. Methods: Clinical and radiological data from 199 SCVST patients were collected and analyzed in this study. Univariate and multivariate logistic regression analyses were conducted for several factors, including age, gender, pregnancy and puerperium, oral contraceptive use, coma state, hemiplegia, sensory dysfunction, cerebral infarction, cerebral hemorrhage, and sinus involvement. Subsequently, an evaluation system was developed based on the odds ratio (OR), and the receiver operating characteristic (ROC) curve was used to determine the prediction accuracy of this evaluation system in another cohort of 32 SCVST patients. Results: Pregnancy and puerperium (OR = 5.525, Conclusion: Pregnancy and puerperium, oral contraceptive use, coma at admission, cerebral hemorrhage, and the number of occluded sinuses are independent risk factors predicting the SCVST progression after anticoagulation. The developed CHOPS score can accurately predict SCVST progression; thus, endovascular or surgical treatment may be considered after anticoagulation when clinically necessary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.